7. Diagnose
7.1. Symptomer
7.2. Utredning
7.3. Andre modaliteter
7.4. Pre-operativ laparoskopi
7.5. Blodprøver – tumormarkører
7.6. Differensialdiagnostikk
7.7. Sammendrag av anbefalinger
Abdelrahman, A. M., Goenka, A. H., Alva-Ruiz, R., Yonkus, J. A., Leiting, J. L., Graham, R. P., Merrell, K. W., Thiels, C. A., ... Truty, M. J. (2022). FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma. Journal of the National Comprehensive Cancer Network, 20(9), 1023-1032 e3.
Al-Hawary, M. M., Francis, I. R., Chari, S. T., Fishman, E. K., Hough, D. M., Lu, D. S., Macari, M., Megibow, A. J., ... Simeone, D. M. (2014). Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology, 270(1), 248-60.
Allen, V. B., Gurusamy, K. S., Takwoingi, Y., Kalia, A., & Davidson, B. R. (2013). Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database of Systematic Reviews, (11), CD009323.
Asbun, H. J., Conlon, K., Fernandez-Cruz, L., Friess, H., Shrikhande, S. V., Adham, M., Bassi, C., Bockhorn, M., ... International Study Group of Pancreatic, S. (2014). When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery. Surgery, 155(5), 887-92.
Ballehaninna, U. K., & Chamberlain, R. S. (2012). The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. Journal of gastrointestinal oncology, 3(2), 105-19.
Dekker, E. N., van Dam, J. L., Janssen, Q. P., Besselink, M. G., DeSilva, A., Doppenberg, D., van Eijck, C. H. J., Nasar, N., ... Trans-Atlantic Pancreatic Surgery, C. (2024). Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study. Journal of Clinical Oncology, , JCO2301311.
Dimarco, M., Cannella, R., Pellegrino, S., Iadicola, D., Tutino, R., Allegra, F., Castiglione, D., Salvaggio, G., ... Vernuccio, F. (2020). Impact of structured report on the quality of preoperative CT staging of pancreatic ductal adenocarcinoma: assessment of intra- and inter-reader variability. Abdominal radiology (New York), 45(2), 437-448.
Dumonceau, J. M., Deprez, P. H., Jenssen, C., Iglesias-Garcia, J., Larghi, A., Vanbiervliet, G., Aithal, G. P., Arcidiacono, P. G., ... Polkowski, M. (2017). Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated January 2017. Endoscopy, 49(7), 695-714.
Farma, J. M., Santillan, A. A., Melis, M., Walters, J., Belinc, D., Chen, D. T., Eikman, E. A., & Malafa, M. (2008). PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms. Annals of Surgical Oncology, 15(9), 2465-71.
Farnes, I., Paulsen, V., Verbeke, C. S., Tonnesen, C. J., Aabakken, L., & Labori, K. J. (2024). Performance and safety of diagnostic EUS FNA/FNB and therapeutic ERCP in patients with borderline resectable and locally advanced pancreatic cancer - results from a population-based, prospective cohort study. Scandinavian Journal of Gastroenterology, 59(4), 496-502.
Fattahi, R., Balci, N. C., Perman, W. H., Hsueh, E. C., Alkaade, S., Havlioglu, N., & Burton, F. R. (2009). Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. Journal of Magnetic Resonance Imaging, 29(2), 350-356.
George, E., Wortman, J. R., Fulwadhva, U. P., Uyeda, J. W., & Sodickson, A. D. (2017). Dual energy CT applications in pancreatic pathologies. British Journal of Radiology, 90(1080), 20170411.
Hartwig, W., Strobel, O., Hinz, U., Fritz, S., Hackert, T., Roth, C., Buchler, M. W., & Werner, J. (2013). CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy. Annals of Surgical Oncology, 20(7), 2188-2196.
Helsedirektoratet (20.10.2020). Nevroendokrine svulster i fordøyelsessystemet – handlingsprogram. [nettdokument]. Oslo: Helsedirektoratet. Hentet 7.03.2025 fra https://www.helsedirektoratet.no/retningslinjer/nevroendokrine-svulster-i-fordoyelsessystemet-handlingsprogram
Huang, Z., & Liu, F. (2014). Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis. Tumour Biology, 35(8), 7459-65.
Kim, J. H., Park, S. H., Yu, E. S., Kim, M. H., Kim, J., Byun, J. H., Lee, S. S., Hwang, H. J., ... Lee, M. G. (2010). Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology, 257(1), 87-96.
Li, J. H., He, R., Li, Y. M., Cao, G., Ma, Q. Y., & Yang, W. B. (2014). Endoscopic ultrasonography for tumor node staging and vascular invasion in pancreatic cancer: a meta-analysis. Digestive Surgery, 31(4-5), 297-305.
Lohr, J. M., Beuers, U., Vujasinovic, M., Alvaro, D., Frokjaer, J. B., Buttgereit, F., Capurso, G., Culver, E. L., ... group, U. E. G. g. w. (2020). European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. United European Gastroenterology Journal, 8(6), 637-666.
Low, G., Panu, A., Millo, N., & Leen, E. (2011). Multimodality imaging of neoplastic and nonneoplastic solid lesions of the pancreas. Radiographics, 31(4), 993-1015.
Madhoun, M. F., Wani, S. B., Rastogi, A., Early, D., Gaddam, S., Tierney, W. M., & Maple, J. T. (2013). The diagnostic accuracy of 22-gauge and 25-gauge needles in endoscopic ultrasound-guided fine needle aspiration of solid pancreatic lesions: a meta-analysis. Endoscopy, 45(2), 86-92.
Mizrahi, J. D., Surana, R., Valle, J. W., & Shroff, R. T. (2020). Pancreatic cancer. Lancet, 395(10242), 2008-2020.
NCCN (2024). NCCN Clinical Practical Guidelines in Oncology: Pancreas Adenocarcinoma. Version 3.2024 Washington, PA: National Comprehensive Cancer Network. Hentet fra https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1455 (krever registrering)
Norsk Gastrointestinal Cancer Gruppe - HPB (2024). Retningslinjer for utredning, behandling og kontroll av cystiske pankreaslesjoner (2 utg.) [s.l.]: NGICG-HPB. Hentet fra https://www.ngicg.no/_files/ugd/2556a8_3ce6eaad8a0042b09e90cc0f0e68f4d8.pdf
Ruff, S. M., & Tsai, S. (2024). Use of Diagnostic Laparoscopy and Peritoneal Washings for Pancreatic Cancer. Surgical Clinics of North America, 104(5), 975-985.
Schima, W., Ba-Ssalamah, A., Goetzinger, P., Scharitzer, M., & Koelblinger, C. (2007). State-of-the-art magnetic resonance imaging of pancreatic cancer. Topics in Magnetic Resonance Imaging, 18(6), 421-9.
Schmidt-Hansen, M., Berendse, S., & Hamilton, W. (2016). Symptoms of Pancreatic Cancer in Primary Care: A Systematic Review. Pancreas, 45(6), 814-8.
Toft, J., Hadden, W. J., Laurence, J. M., Lam, V., Yuen, L., Janssen, A., & Pleass, H. (2017). Imaging modalities in the diagnosis of pancreatic adenocarcinoma: A systematic review and meta-analysis of sensitivity, specificity and diagnostic accuracy. European Journal of Radiology, 92, 17-23.
Ukegjini, K., Steffen, T., Tarantino, I., Jonas, J. P., Rossler, F., Petrowsky, H., Gubler, C., Muller, P. C., & Oberkofler, C. E. (2023). Systematic review on groove pancreatitis: management of a rare disease. BJS Open, 7(5)
Yamauchi, F. I., Ortega, C. D., Blasbalg, R., Rocha, M. S., Jukemura, J., & Cerri, G. G. (2012). Multidetector CT evaluation of the postoperative pancreas. Radiographics, 32(3), 743-64.
Yin, Q., Zou, X., Zai, X., Wu, Z., Wu, Q., Jiang, X., Chen, H., & Miao, F. (2015). Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode. European Journal of Radiology, 84(12), 2470-6.
Siste faglige endring: 28. mars 2025